SCHEMBL4155378

SCHEMBL4155378

CCCCCCCCCCCCC(=O)Oc1c(-c2ccccc2)oc2cc(O)cc(O)c2c1=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 3/20 0.63
ADORA3 P0DMS8 2/20 0.56
POLH Q9Y253 5/20 0.56
CYP3A4 P08684 3/20 0.54
CYP2D6 P10635 3/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
MAPT P10636 2/20 0.54
CA12 O43570 1/20 0.54
CYP1A1 P04798 1/20 0.54
CYP1A2 P05177 1/20 0.54
BCHE P06276 1/20 0.54
P4HB P07237 1/20 0.54
CYP19A1 P11511 1/20 0.54
CYP2C9 P11712 1/20 0.54
MAOA P21397 1/20 0.54
ACHE P22303 1/20 0.54
CA4 P22748 1/20 0.54
MAOB P27338 1/20 0.54
ADORA2A P29274 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4166839 1.00 ABCB1 (0.63) ABCB1ADORA3POLHCYP3A4CYP2D6
SCHEMBL4169975 1.00 ABCB1 (0.63) ABCB1ADORA3POLHCYP3A4CYP2D6
SCHEMBL4167855 1.00 ABCB1 (0.63) ABCB1ADORA3POLHCYP3A4CYP2D6
SCHEMBL4162087 1.00 ABCB1 (0.63) ABCB1ADORA3POLHCYP3A4CYP2D6
SCHEMBL4163581 1.00 ABCB1 (0.63) ABCB1ADORA3POLHCYP3A4CYP2D6
SCHEMBL4155185 1.00 ABCB1 (0.63) ABCB1ADORA3POLHCYP3A4CYP2D6
SCHEMBL4161844 1.00 ABCB1 (0.63) ABCB1ADORA3POLHCYP3A4CYP2D6
SCHEMBL4161068 1.00 ABCB1 (0.63) ABCB1ADORA3POLHCYP3A4CYP2D6
SCHEMBL4165973 0.99 ABCB1 (0.64) ABCB1ADORA3POLHCYP3A4CYP2D6
SCHEMBL4163413 0.94 ABCB1 (0.57) ABCB1ADORA3POLHCYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090130051-A1 Flavonoid Compounds and Uses Thereof HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) 2009-05-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090130051-A1 Flavonoid Compounds and Uses Thereof CAT, NQO1, GPX4 ABCB1 1605/4885ADORA3 2776/4885POLH 3392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.